Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited financing, and few fixed-dose combination (FDC) products. Globa...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 May 2010
|
| In: |
Globalization and health
Year: 2010, Volume: 6, Pages: 9 |
| ISSN: | 1744-8603 |
| DOI: | 10.1186/1744-8603-6-9 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1744-8603-6-9 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1744-8603-6-9 |
| Author Notes: | Brenda Waning, Margaret Kyle, Ellen Diedrichsen, Lyne Soucy, Jenny Hochstadt, Till Bärnighausen, Suerie Moon |
| Summary: | Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited financing, and few fixed-dose combination (FDC) products. Global initiatives aim to promote efficient global ARV markets, yet little is known about market dynamics and the impact of global policy interventions. |
|---|---|
| Item Description: | Gesehen am 18.08.2017 |
| Physical Description: | Online Resource |
| ISSN: | 1744-8603 |
| DOI: | 10.1186/1744-8603-6-9 |